日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Economic Analysis of New Single-Inhaler Triple Therapies in Patients with COPD in the UK

英国慢性阻塞性肺病患者新型单吸入器三联疗法的经济分析

期刊:International Journal of Chronic Obstructive Pulmonary Disease
影响因子:3.1
doi:10.2147/COPD.S475748
Cai, Rui; Martin, Alan A; Ge, Yuchen; Risebrough, Nancy A; Haeussler, Katrin; Compton, Christopher; Halpin, David M G; Ismaila, Afisi S
发表日期：2025
文献求助 收藏

Is single-inhaler triple therapy for COPD cost-effective in the UK? The IMPACT trial

在英国，单吸入器三联疗法治疗慢性阻塞性肺病是否具有成本效益？IMPACT试验

期刊:Erj Open Research
影响因子:4
doi:10.1183/23120541.00333-2021
Martin, Alan; Shah, Dhvani; Ndirangu, Kerigo; Anley, Glenn A; Okorogheye, Gabriel; Schroeder, Melanie; Risebrough, Nancy; Ismaila, Afisi S
发表日期：2022
文献求助 收藏

Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis

氟替卡松糠酸酯/乌美溴铵/维兰特罗（FF/UMEC/VI）三联疗法与其他疗法治疗慢性阻塞性肺疾病的比较：一项网络荟萃分析

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-022-02231-0
Ismaila, Afisi S; Haeussler, Katrin; Czira, Alexandrosz; Youn, Ji-Hee; Malmenäs, Mia; Risebrough, Nancy A; Agarwal, Jatin; Nassim, Maria; Sharma, Raj; Compton, Chris; Vogelmeier, Claus F; Han, MeiLan K; Halpin, David M G
慢性阻塞性肺疾病
发表日期：2022
文献求助 收藏

Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial

晚期慢性阻塞性肺病患者的单吸入器三联疗法：基于IMPACT试验的医疗资源利用数据及相关成本的贝叶斯建模

期刊:International Journal of Chronic Obstructive Pulmonary Disease
影响因子:3.1
doi:10.2147/COPD.S342244
Gabrio, Andrea; Gunsoy, Necdet B; Baio, Gianluca; Martin, Alan; Paly, Victoria F; Risebrough, Nancy; Halpin, David M G; Singh, Dave; Wise, Robert A; Han, MeiLan K; Martinez, Fernando J; Criner, Gerard J; Martin, Neil; Lipson, David A; Ismaila, Afisi S
发表日期：2022
文献求助 收藏

Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial

英国慢性阻塞性肺病患者单吸入器三联疗法与多吸入器三联疗法的成本效益分析：INTREPID试验

期刊:International Journal of Chronic Obstructive Pulmonary Disease
影响因子:3.1
doi:10.2147/COPD.S370577
Halpin, David M G; Kendall, Robyn; Shukla, Soham; Martin, Alan; Shah, Dhvani; Midwinter, Dawn; Beeh, Kai M; Kocks, Janwillem W H; Jones, Paul W; Compton, Chris; Risebrough, Nancy A; Ismaila, Afisi S
发表日期：2022
文献求助 收藏

Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UK

英国慢性阻塞性肺病单吸入器三联疗法的成本效益分析

期刊:Erj Open Research
影响因子:4
doi:10.1183/23120541.00480-2020
Fenwick, Elisabeth; Martin, Alan; Schroeder, Melanie; Mealing, Stuart J; Solanke, Oyinkansola; Risebrough, Nancy; Ismaila, Afisi S
发表日期：2021
文献求助 收藏

Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial

评估复发和难治性侵袭性组织学淋巴瘤挽救性化疗相关的间接医疗成本：加拿大癌症试验组 (CCTG) LY.12 临床试验的子集分析

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol28020119
Prica, Anca; Hay, Annette E; Crump, Michael; Mittmann, Nicole; Shepherd, Lois E; Meyer, Ralph M; Imrie, Kevin I; Risebrough, Nancy; Djurfeldt, Marina; Chen, Bingshu E; Cheung, Matthew C
肿瘤
淋巴瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Correction to: Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspective

更正：在有症状的慢性阻塞性肺疾病患者中，乌美溴铵/维兰特罗 62.5/25 微克与噻托溴铵/奥达特罗 5/5 微克的成本效益分析：西班牙国家医疗保健系统视角

期刊:Respiratory Research
影响因子:5
doi:10.1186/s12931-019-0985-2
Driessen, M T; Whalen, J; Buguth, B Seewoodharry; Vallejo-Aparicio, L A; Naya, I P; Asukai, Y; Alcázar-Navarrete, B; Miravitlles, M; García-Río, F; Risebrough, N A
慢性阻塞性肺疾病
发表日期：2019
文献求助 收藏

Long-term cost and utility consequences of short-term clinically important deterioration in patients with chronic obstructive pulmonary disease: results from the TORCH study

慢性阻塞性肺疾病患者短期临床显著恶化的长期成本和效用后果：TORCH 研究的结果

期刊:International Journal of Chronic Obstructive Pulmonary Disease
影响因子:3.1
doi:10.2147/COPD.S188898
Paly, Victoria Federico; Naya, Ian; Gunsoy, Necdet B; Driessen, Maurice T; Risebrough, Nancy; Briggs, Andrew; Ismaila, Afisi S
慢性阻塞性肺疾病
发表日期：2019
文献求助 收藏

Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial

慢性阻塞性肺疾病每日一次单吸入器三联疗法的成本效益：IMPACT试验

期刊:International Journal of Chronic Obstructive Pulmonary Disease
影响因子:3.1
doi:10.2147/COPD.S216072
Ismaila, Afisi S; Risebrough, Nancy; Schroeder, Melanie; Shah, Dhvani; Martin, Alan; Goodall, Emma C; Ndirangu, Kerigo; Criner, Gerard; Dransfield, Mark; Halpin, David Mg; Han, MeiLan K; Lomas, David A
慢性阻塞性肺疾病
发表日期：2019
文献求助 收藏